Getting Compensated For Yaz Blood Clots
Yaz is a third generation oral contraceptive which is also sold under the brand names Yasmin and Ocella in the United States. Since its introduction, there have been serious concerns about the increased risk for Yaz blood clots compared to second generation birth control pills. There are currently over 11,500 lawsuits pending in U.S. federal courts for injuries arising from Yaz side effects.
How Is Yaz Different?
All combination oral contraceptives contain two synthesized female hormones, estrogen and progesterone. Unlike other birth control pills, Yaz, Yasmin and Ocella use a unique synthetic progesterone called drospirenone. In interim reports from a 10 year clinical study being conducted by Kaiser Permanente of Northern California, drospirenone has been linked up to a 40% increased risk of Yaz blood clots compared to the synthetic hormones used in second generation oral contraceptives.
Complications of Blood Clots
The blood clots associated with the use of Yaz may be deep vein thrombosis. These are blood clots that form within the deep veins of the legs and can be carried through the circulatory system to the lungs, heart or brain. Serious complications of Yaz blood clots include pulmonary embolism (a clot that blocks blood circulation in the lungs), heart attack and stroke. All of these medical conditions require treatment in a hospital and can result in permanent disability or death.
Yaz Marketing Criticized by FDA
Yaz was developed by the Berlex Pharmaceutical Co. of Germany and released in Europe in 2001. Berlex was acquired by Bayer Pharmaceuticals that began an aggressive marketing campaign for Yaz in the U.S. despite early indications that there might be a link between drospirenone and an increased risk for Yaz blood clots. Bayer was repeatedly chastised by the FDA for their advertising claims that Yaz could be used to treat a variety of hormone related conditions like acne and premenstrual dysphoric disorder.
Black Box Warning
All oral contraceptives have a warning that smoking increases the risk of blood clots especially in women over 35, but the FDA ordered Bayer to include a black box warning on the Yaz label. The black box warning is the strongest action the FDA can take other than removing a drug from the market. Although the black box warning is directed at smokers, there is growing evidence that non smokers under the age of 35 also have a substantially increased risk of Yaz blood clots.
Compensation for Yaz Injuries
Anyone who has suffered injuries from Yaz blood clots may be entitled to compensation for their medical expenses, lost wages, other financial losses and any permanent disability that arose from the injury. Individuals who believe they are entitled to compensation for Yaz injuries should consult an attorney specializing in product liability cases. A consultation with a Yaz lawyer is free and the lawyer does not receive a fee unless his or her client receives compensation for their injuries.
Drug Makers withheld Reports from FDA
A former FDA commissioner, David Kessler, is expected to testify in upcoming lawsuits that Bayer and Berlex deliberately withheld reports of Yaz blood clots from the FDA. Plaintiffs’ lawyers allege that the drug makers were aware of the increased risk of blood clots and other side effects linked to drospirenone and failed to adequately warn Yaz users of the danger. Due to the large number of Yaz lawsuits, the case has been declared a multijurisdiction litigation in the Southern District of Illinois, Judge David Herndon presiding.
What Is a Multijurisdiction Litigation?
A multijurisdiction litigation (MDL) is a method used by federal courts to streamline the legal process where there are multiple cases with a similar cause of action against the same defendant(s). By consolidating the cases for discovery purposes only, the court avoids duplicating evidentiary proceedings for each case. The first Yaz trial, for a woman who suffered a pulmonary embolism from Yaz blood clots, was scheduled to begin in Jan. 2012, but has been delayed and ordered into mediation (settlement negotiations) by Judge Herndon.
The Time to File a Lawsuit is Limited
The law limits the time an injured person has to file a lawsuit. While the limits vary from state to state, they are usually between one and two years. It is vital that anyone suffering from injuries related to Yaz blood clots contact a lawyer as soon as possible to avoid forfeiting their right to legal compensation. A Yaz lawyer can help women receive money for their medical expenses and any disability arising from their injuries.
If you or someone you know has suffered from Yaz blood clots, you can get a free compensation evaluation by visiting our website and completing the short questionnaire. An experienced legal professional will contact you and provide answers to your questions and assistance in finding a lawyer to get financial compensation (if you qualify) of your expenses, pain and suffering.